Department Of Pharmacology

Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read More

Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016. Read More

In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide a new way to control the deadliest animal on Earth. Read More

Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk. Read More

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB). Read More

A compound found in buckwheat seeds extends the lifespan of worms, Vanderbilt investigators have discovered. Read More

A protein that plays a powerful role in learning and memory may be a key to improving treatment of a rare autism spectrum disorder called Pitt-Hopkins syndrome (PTHS), a new study suggests. Read More

Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression. Read More

The 2C-subtype of the serotonin receptor (5HT2C), which binds the neurotransmitter serotonin, plays an important role in regulating food intake and metabolism. Read More

Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment. Read More

Meagan Quinlan, a Pharmacology graduate student in the laboratory of Randy Blakely, Ph.D., honored her mentor Tuesday during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall. Read More

New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections. Read More

A new animal model can be used to “dissect” the inflammatory response to infection. Read More

Joseph Coyle, M.D., an expert in the neurobiology of serious mental illness, will deliver the next Flexner Discovery Lecture on Thursday, March 10. Read More

C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment. Read More

BethAnn McLaughlin, Ph.D., a neuroscientist at Vanderbilt University Medical Center, has been invited to serve as a reviewing editor for the Journal of Neuroscience, the flagship publication of the Society of Neuroscience, one of the world’s largest scientific societies. Read More

A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells. Read More

For her contributions to public communication, outreach and education about neuroscience, Nicole Baganz, Ph.D., a postdoctoral fellow in Pharmacology, received the 2015 Next Generation Award from the Society for Neuroscience. Read More

Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior. Read More

Vanderbilt study adds to the mounting role for inflammatory signaling in obesity. Read More